This bill amends current law to allow licensed physical therapists in Kansas to perform certain capillary blood tests, specifically those classified as CLIA-waived tests by the Centers for Medicare and Medicaid Services. The permitted tests include lactate and blood glucose, which can be used to gather information related to muscle metabolism, exercise tolerance, or rehabilitation status. However, the bill clarifies that such testing does not grant physical therapists the authority to diagnose medical conditions and that they cannot bill third-party payers for these tests as standalone reimbursable services.

Additionally, the bill introduces a requirement for written consent from the patient or their representative before any point-of-care testing can be performed. This consent must include a disclosure of costs and an acknowledgment of financial responsibility. The bill emphasizes that testing must be conducted in accordance with federal law and manufacturer instructions, and results are intended to support physical therapy evaluation and treatment planning rather than serve as diagnostic tools.